Presentation:  4:00-5:00PM
Discussion & Reception: 5:00-6:00PM

Presentation at MGH: Haber Auditorium

With Live Videoconference to DFCI: Dana 1620

Sponsored by AMGEN

C Glenn Begley, MBBS, PhD, VP, Hematology & Oncology Research
Jan Pinkas, PhD, Senior Scientist, Oncology Research
Douglas Saffran, PhD, Principal Scientist, Oncology Research

Topics/Products Presented:
 Amgen Research Overview
-Amgen 479: Anti-CD221 (IGF-IR) Monoclonal Antibody
-Amgen 706: Oral, multi-kinase inhibitor with anti-angiogenic activity
-Denosumab: Anti-RANKL Monoclonal Antibody

Note: Presentations are designated for DF/HCC members only and are not open to the public.

For more information, please e-mail Petra Loesch or contact by phone at 617-724-3867.